Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 104 of 144 pages ‹ First < 102 103 104 105 106 > Last ›
HSL4595
Hale VG, Woo K, Lipton HL.
Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world.
Health Aff (Millwood) 2005 Jul-Aug; 24:(4):1057-63
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16012146&db=PubMed&url=http://content.healthaffairs.org/cgi/pmidlookup?view=long&pmid=16012146
HSL5130
Senior K.
Neglected diseases: getting less neglected?
Drug Discov Today 2005 Jul 1; 10:(13):878
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=15993802&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S1359-6446(05)03519-1
HSL5161
Ellis CN, Pillitteri JL, Kyle TK, Ertischek MD, Burton SL, Shiffman S.
Consumers appropriately self-treat based on labeling for over-the-counter hydrocortisone.
J Am Acad Dermatol 2005 Jul 01; 53:(1):41-51
http://linkinghub.elsevier.com/retrieve/pii/S0190962205004408
HSL5228
Wager E, Jacobs A.
Response to 'the corporate coauthor'.
J Gen Intern Med 2005 Jul 01; 20:(7):672
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.051181.x
HSL5349
Miller RA, Gardner RM, Johnson KB, Hripcsak G.
Clinical decision support and electronic prescribing systems: a time for responsible thought and action.
J Am Med Inform Assoc 2005 Jul-Aug 01; 12:(4):403-9
http://www.jamia.org/cgi/content/full/12/4/403
HSL5836
Cohen D.
Bold suggestion by Smith.
PLoS Med 2005 Jul 01; 2:(7):e226
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16033320
HSL5837
Sheldon T.
Focus on the funding and production of evidence rather than its publication.
PLoS Med 2005 Jul 01; 2:(7):e222
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16033316
HSL5838
Marcovitch H.
Little fish are less likely to take the bait.
PLoS Med 2005 Jul 01; 2:(7):e221
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16033315
HSL5839
Sackett D.
Might banning trial publication do more harm than good?
PLoS Med 2005 Jul 01; 2:(7):e220
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020220
HSL5840
Senn S.
Bitter pills and puffed trials.
PLoS Med 2005 Jul 01; 2:(7):e219
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16033313
HSL5841
Frighi V.
Medical journals, academia, and industry-sponsored clinical trials.
PLoS Med 2005 Jul 01; 2:(7):e218
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16033312
HSL5843
Why PLoS sponsored a roundtable of medical whistleblowers.
PLoS Med 2005 Jul 01; 2:(7):e208
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15913415
HSL6236
Bergk V, Haefeli WE, Gasse C, Brenner H, Martin-Facklam M.
Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature.
Eur J Clin Pharmacol 2005 Jul 01; 61:(5-6):327-35
http://www.springerlink.com/content/l02745780316mr4t/
HSL20038
Fleming K
'Gift' pens and notepads labelled unethical
Medical Observer 2005 July 111
HSL2073
Nuwaha F, Okware J, Ndyomugyenyi R.
Predictors of compliance with community-directed ivermectin treatment in Uganda: quantitative results.
Trop Med Int Health 2005 Jul; 10:(7):659-67
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-3156.2005.01436.x?cookieSet=1
HSL2118
Cummings KC, Rosenberg J, Vugia DJ.
Beliefs about appropriate antibacterial therapy, California.
Emerg Infect Dis 2005 Jul; 11:(7):1138-41
http://www.cdc.gov/ncidod/EID/vol11no07/05-0112.htm
HSL2125
Richards T.
Global university course launched on health advocacy
Jul 2005 Jul; 331:256
http://bmj.bmjjournals.com/cgi/content/extract/331/7511/256-a
HSL2126
Roehr B.
Report argues US should not pay more than rest of world to fight HIV/AIDS
BMJ 2005 Jul; 331:256
http://bmj.bmjjournals.com/cgi/content/extract/331/7511/256-b
HSL2127
Burton B.
US governor plans to import cheaper drugs from Australia and New Zealand
BMJ 2005 Jul; 331:256.
http://bmj.bmjjournals.com/cgi/content/extract/331/7511/256-c?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=burton+b&andorexactfulltext=and&searchid=1124344014667_19124&stored_search=&FIRSTINDEX=0&sortspec=relevance&resourcetype=1
HSL2129
Expression of concern
BMJ 2005 Jul; 331:266
http://bmj.bmjjournals.com/cgi/content/full/331/7511/266
HSL2273
Flordellis CS.
The emergence of a new paradigm of pharmacogenomics.
Pharmacogenomics 2005 Jul; 6:(5):515-26
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16014001&query_hl=5
HSL2274
Gleason PP, Williams C, Hrdy S, Hartwig SC, Lassen D.
Medical and pharmacy expenditures after implementation of a cyclooxygenase-2 inhibitor prior authorization program.
Pharmacotherapy 2005 Jul; 25:(7):924-34
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed
HSL3492
Lenzer J .
What can we learn from medical whistleblowers?
PLoS Med 2005 Jul; 2:(7):e209
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020209
HSL3716
Frantz S.
Big companies helped by safe harbour ruling.
Nat Rev Drug Discov 2005 Jul 01; 4:(7):525-6
HSL3727
Berndt ER, Gottschalk AH, Philipson TJ, Strobeck MW.
Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates.
Nat Rev Drug Discov 2005 Jul; 4:(7):545-54
http://www.nature.com/nrd/journal/v4/n7/abs/nrd1774_fs.html;jsessionid=6DC8F63114D6CEAB8D0F8190F4F3072B
HSL3742
Taylor JP, Evers S, McKenna M.
Determinants of healthy eating in children and youth.
Can J Public Health 2005 Jul-Aug; 96:
HSL4803
Damodaran RT.
Brand confusion causes allergic dermatitis.
J Postgrad Med 2005 Jul-Sep; 51:(3):242
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3153&uid=16333208&db=PubMed&url=http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2005;volume=51;issue=3;spage=242;epage=242;aulast=Damodaran
HSL4806
Wertheimer AI, Santella TM.
Counterfeit drugs: defining the problem and finding solutions.
Expert Opin Drug Saf 2005 Jul; 4:(4):619-22
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3204&uid=16011440&db=PubMed&url=http://www.ashley-pub.com/doi/abs/10.1517/14740338.4.4.619
HSL4830
Althof SE, Goldstein I, Becher E, Giraldi A, Vardi Y, Dennerstein L, Marson L, Brotto L, Schreiner-Engel P, Wallen K, Clayton A, Altman A, Kingsberg S, Shabsigh R; Board of Directors of the International Society for the Study of Women's Sexual Health.
The other side: failure in fair and balanced reporting.
J Sex Med 2005 Jul; 2:(4):583-4
HSL5374
Rosenbloom ST, Geissbuhler AJ, Dupont WD, Giuse DA, Talbert DA, Tierney WM, Plummer WD, Stead WW, Miller RA.
Effect of CPOE user interface design on user-initiated access to educational and patient information during clinical care.
J Am Med Inform Assoc 2005 Jul-Aug; 12:(4):458-73
http://www.jamia.org/cgi/content/full/12/4/458
HSL7407
Napoli M.
Why Do We Need A Publicly Funded, Publicly Accessible Database Of Clinical Trials?
Center for Medical Consumers 2005 Jul
http://www.medicalconsumers.org/pages/StopDrugCompaniesfromHidingNegativeResults.html
HSL8798
Carpenter D.
A proposal for financing postmarketing drug safety studies by augmenting FDA user fees.
Health Aff (Millwood) 2005 Jul-Dec; Suppl:
http://content.healthaffairs.org/cgi/reprint/hlthaff.w5.469v1
HSL9361
Bailey PG.
New ethical code reflects expectations for industry behavior.
J Am Coll Radiol 2005 Jul; 2:(7):622-5
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17411889&query_hl=7&itool=pubmed_docsum
HSL1702
Kelleher S.
Suddenly Sick Part 6 ( Female Sexual Dysfunction)
The Seattle Times 2005 Jun 30
HSL20185
Limprecht E
Web watchdog bites media medical coverage
Australian Doctor 2005 Jun 304
http://www.australiandoctor.com.au/news/latest-news/web-watchdog-bites-media-medical-coverage
HSL1701
Kelleher S.
Suddenly Sick Part 5 ( Deep Vein Thrombosis )
The Seattle Times 2005 Jun 29
HSL1919
Safety and Efficacy of SSRIs in Children and Adolescents
American Medical Association 2005 Jun 29
http://www.ama-assn.org/ama/pub/category/print/15186.html
HSL1700
Kelleher S.
Suddenly Sick Part 4 ( Osteoporosis )
The Seattle Times 2005 Jun 28
HSL1659
Mansfield PR.
Response to Pfizer
BMJ 2005 Jun 27;
http://bmj.bmjjournals.com/cgi/eletters/328/7444/879#110681
HSL1699
Kelleher S.
Suddenly Sick Part 3 ( Obesity)
The Seattle Times 2005 Jun 27
HSL1644
Kelleher S.
Suddenly Sick Part 1 (Introduction)
The Seattle Times 2005 Jun 26
HSL1648
Griffith D.
Health Group's Funding Faulted
The Sacramento Bee 2005 Jun 26
http://www.sacbee.com/content/news/projects/drugs/story/13132395p-13976434c.html
HSL1703
Wilson D.
Suddenly Sick Part 2 (Hypertension)
The Seattle Times 2005 Jun 26
HSL1649
Lewis L.
AstraZenica faces threat of charges in Japan
Times Online 2005 Jun 24
http://business.timesonline.co.uk/article/0,,9068-1667153,00.html
HSL5846
Toop L, Richards D, Dowell T.
Response to Maubach and Hoek's paper on GP attitudes to DTCA
N Z Med J. 2005 Jun 24; 118:(1217):U1543
HSL1621
Waxman H.
The Lessons of Vioxx - Drug Safety and Sales
The New England Journal of Medicine 2005 Jun 23; 352:(25):2576-2578
HSL1645
Avorn J.
Torcetrapib and atorvastatin--should marketing drive the research agenda?
N Engl J Med 2005 Jun 23; 352:(25):2573-6
http://content.nejm.org/cgi/content/extract/352/25/2573
HSL1696
Agovino T.
Merck Tried to Alter Vioxx in 2000
Associated Press 2005 Jun 23
HSL13059
Antidepressants barely better than placebos
New Scientist 2005 Jun 23
http://www.newscientist.com/channel/health/mental-health/mg18725096.000-antidepressants-barely-better-than-placebos.html
HSL1834
Daemmrich A., Bowden M.
A RISING DRUG INDUSTRY
Chemical and Engineering News 2005 Jun 20
http://pubs.acs.org/cen/coverstory/83/8325/index.html
HSL1831
Pharma Reformulates Marketing Plans
Eye For Pharma 2005 Jun 19
http://www.eyeforpharma.com/print.asp?news=46904
HSL1634
Metherell M.
Lung cancer drugs will cost more
The Sydney Morning Herald 2005 Jun 17;
http://www.smh.com.au/news/National/Lung-cancer-drugs-will-cost-more/2005/06/16/1118869048092.html
HSL20082
Limprecht E
GP ownership at core of practice software battle
Australian Doctor 2005 Jun 175
http://www.australiandoctor.com.au/news/latest-news/gp-ownership-at-core-of-practice-software-battle
HSL1632
Rowland C.
Doctors fight over drug firm influence: Some in hypertension society hit fees paid to members for talks
The Boston Globe 2005 Jun 16
HSL1633
AstraZeneca to appeal 60 mln eur EU fine; analysts shrug off impact
2005 Jun 15;
HSL1635
Pear R.
Medicare Officials Insisting on Wider Choices in Drug Benefits
The New York Times 2005 Jun 15;
http://www.nytimes.com/2005/06/15/health/15drug.html?ei=5070&en=be3d33b7b081
HSL3765
Pollack A.
Justices expand rights to experiment with patented drugs.
NY Times (Print) 2005 Jun 14; :C1,:
HSL1631
Jackson L.
A marketing breakthrough
Mediawatch ABC Online 2005 Jun 13;
http://www.abc.net.au/mediawatch/transcripts/s1390967.htm
HSL1695
Zipkin DA, Steinman MA.
Interactions Between Pharmaceutical Representatives and Doctors in Training: A thematic review.
J Gen Intern Med 2005 Jun 13; 20:(8):777-86
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.0134.x
HSL1628
Mandel M.
Smokin' family feud: Michele Mandel visits the home of the Kaczmarczyks. He's on a hunger strike because she won't quit smoking
The Toronto Sun 2005 Jun 12;
HSL1629
Harris G, Koli E.
Lucrative Drug, Danger Signals and the F.D.A.
2005 Jun 10;
HSL1630
Health Canada to receive FDA award
CNW Telbec 2005 Jun 10;
HSL4443
Limprecht E.
Celebrex claim costs Pfizer $25,000
Australian Doctor Weekly 2005 Jun 9
HSL14963
Prakash S.
All Things Considered Part 1: Documents Suggest Merck Tried to Censor Vioxx Critics
NPR.org 2005 Jun 9
http://www.npr.org/templates/story/story.php?storyId=4696609
HSL14964
Prakash S.
All Things Considered Part 2: Did Merck Try to Censor Vioxx Critics?
NPR.org 2005 Jun 9
http://www.npr.org/templates/story/story.php?storyId=4696711
HSL14965
Neel J.
Medical Schools and Drug Firm Dollars
NPR.org 2005 Jun 9
http://www.npr.org/templates/story/story.php?storyId=4696316
HSL1623
Shapiro N.
Death by Natural Causes
2005 Jun 8-14;
HSL1624
Words to the wise healthcare consumer: Approach with caution
2005 Jun 8;
HSL1626
Berenson A.
At Pfizer, the Isolation Increases for a Whistle-Blower: No man is an island. But Peter Rost is getting close.
2005 Jun 8;
HSL1625
Don't use growth hormone sold over web: Health Canada
CBC News 2005 Jun 7;
HSL2036
Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, Henderson KM, Maguire J, Stokes BJ, Macdonald GJ, Day RO.
Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.
Med J Aust 2005 Jun 6; 182:(11):557-60
http://www.mja.com.au/public/issues/182_11_060605/hen10805_fm.html
HSL2133
Lindberg M.
[When will we see "Physicians without sponsors" in Sweden?]
Lakartidningen 2005 Jun 6-12; 102:(23):1830
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15997555&query_hl=8
HSL1598
Carlisle W.
Do We Have Medication For You!
Radio National (Australian Broadcasting Commission) 2005 Jun 5
HSL1622
Levin M.
Firm Removed Mercury From Nasal Spray, Not Infant Shots: Wyeth used thimerosal in vaccines for years after it did away with the chemical in Dristan.
The LA Times 2005 Jun 4;
HSL3752
Bergmann JF, Champion K, Mouly S, Mahe I.
[Is a further editorial on coxibs needed?]
Presse Med 2005 Jun 4; 34:(10):699-700
http://www.masson.fr/masson/portal/bookmark;jsessionid=3453F867FA58D6054CC1747956B51796.lbmastin2?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=100&CodeRevue4=PME&Path=REVUE/PME/2005/34/10/ARTICLE11274683021.xml&Locations=
HSL1627
Anderson C.
Court: Pharmacists Can Be Liable for Drugs
Associated Press 2005 Jun 3;
HSL1706
Vallance P.
Developing an open relationship with the drug industry
The Lancet ( Early Online Publication ) 2005 Jun 2; 366:
http://www.thelancet.com/journals/lancet/article/PIIS0140673605668353/fulltext
HSL1602
Editorial .
Hiding the Data on Drug Trials
The New York Times 2005 Jun 1;
HSL1618
Kelton E.
Sales tactics, whistleblowers and qui tam lawsuits in the pharmaceutical industry
Cafe Pharma (Internet) Date uncertain 2005 Jun
HSL1688
Stocks N, Allan J, Mansfield PR.
Management of hyperlipidaemia.
Aust Fam Physician 2005 Jun; 34:(6):447-53
http://www.racgp.org.au/document.asp?id=17049
HSL1818
Dubovsky SL.
Who is teaching psychopharmacology? Who should be teaching psychopharmacology?
Academic Psychiatry 29:155-161, June 2005 2005 Jun 01; 29:155-161
http://ap.psychiatryonline.org/cgi/content/full/29/2/155
HSL3590
Direct-to-consumer advertising: impact on prescribing.
Child Health Alert 2005 Jun; 24:5-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16134243&dopt=Abstract
HSL3600
Bateman C.
Government 'encouraging snake-oil salesman' Rath.
S Afr Med J 2005 Jun 01; 95:(6):372,
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3401&uid=16100880&db=PubMed&url=http://blues.sabinet.co.za/WebZ/Authorize?sessionid=0:autho=pubmed:password=pubmed2004&/AdvancedQuery?&format=F&next=images/ejour/m_samj/m_samj_v95_n6_a4.pdf
HSL3714
Dwyer P.
Pharmacists & pharmaceutical manufacturers: some ethical considerations.
Med Law 2005 Jun 01; 24:(2):437-54
HSL3741
Pfizer sponsors study on usability for low-literacy users.
Internet Healthc Strateg 2005 Jun 01; 7:(6):10-1
HSL3745
Backer TE, Dearing J, Singhal A, Valente T.
Writing with Ev--words to transform science into action.
J Health Commun 2005 Jun 01; 10:(4):289-302
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3396&uid=16036736&db=pubmed&url=http://journalsonline.tandf.co.uk/Index/10.1080/10810730590949996
HSL3748
Stokowski LA.
FDA strengthens labeling for long-acting penicillins.
Adv Neonatal Care 2005 Jun 01; 5:(3):123-4
HSL3760
Timimi S.
Psychiatry has effectively become a commodity that is being sold to the drug industry.
Ment Health Today 2005 Jun 01; :21:
HSL3762
Chang NS, Simone AF, Schultheis LW.
From the FDA: what's in a label? A guide for the anesthesia practitioner.
Anesthesiology 2005 Jul 01; 103:(1):179-85
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3159&uid=15983471&db=pubmed&url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0003-3022&volume=103&issue=1&spage=179
HSL3764
Santini C.
[The technicoregulatory situation in France for manufactured homeopathic medications]
Ann Pharm Fr. 2005 Jun 01; 63:(3):212-6
http://www.masson.fr/masson/portal/bookmark;jsessionid=834D108D28A717299DF7A104005633A1.lbmastin2?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=260&CodeRevue4=APF&Path=REVUE/APF/2005/63/3/ARTICLE11190167176.xml&Locations=
HSL3766
Guaiana G, Andretta M, Corbari L, Mirandola M, Sorio A, D'Avanzo B, Barbui C.
Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000.
J Clin Psychiatry 2005 Jun 01; 66:(6):750-5
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3091&uid=15960569&db=pubmed&url=http://article.psychiatrist.com/?ContentType=START&ID=10001340
HSL3770
Fineberg HV.
Reply to "Can the Institute of Medicine review the FDA?".
Nat Med 2005 Jun;11(6):589. 2005 Jun 01; 11:(6):589
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3094&uid=15937463&db=pubmed&url=http://dx.doi.org/10.1038/nm0605-589a
HSL3771
Watson J.
Vitamin guru provokes wRath of scientists, activists.
Nat Med 2005 Jun 01; 11:(6):581
http://www.nature.com/doifinder/10.1038/nm0605-581a
HSL3772
Diller L.
Antidepressants and children's depression.
Am J Psychiatry 2005 Jun 01; 162:(6):1226-7
http://ajp.psychiatryonline.org/cgi/content/full/162/6/1226-a
HSL3775
Jackson G.
Generic prescribing -- the chaos continues.
Int J Clin Pract 2005 Jun 01; 59:(6):618
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3046&uid=15924586&db=pubmed&url=http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1368-5031&date=2005&volume=59&issue=6&spage=618
HSL3781
Denneboom W, Dautzenberg MG, Grol R, De Smet PA.
User-related pharmaceutical care problems and factors affecting them: the importance of clinical relevance.
J Clin Pharm Ther 2005 Jun 01; 30:(3):215-23
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3046&uid=15896238&db=pubmed&url=http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0269-4727&date=2005&volume=30&issue=3&spage=215
HSL3787
Dorfman L, Wallack L, Woodruff K.
More than a message: framing public health advocacy to change corporate practices.
Health Educ Behav 2005 Jun 01; 32:(3):320-36
http://heb.sagepub.com/cgi/reprint/32/3/320
HSL3799
Neville L, Thomas M, Bauman A.
Food advertising on Australian television: the extent of children's exposure.
Health Promot Int 2005 Jun 01; 20:(2):105-12
http://heapro.oxfordjournals.org/cgi/content/full/20/2/105
HSL4553
Rasmussen LM.
The ethics and aesthetics of for-profit bioethics consultation.
HEC Forum 2005 Jun; 17:(2):94-121
HSL6090
Tobi H, Scheers T, Netjes KA, Mulder EJ, de Bildt A, Minderaa RB.
Drug utilisation by children and adolescents with mental retardation: a population study.
Eur J Clin Pharmacol 2005 Jun 01; 61:(4):297-302
http://www.springerlink.com/content/r36010x80235t0k5/
Page 104 of 144 pages ‹ First < 102 103 104 105 106 > Last ›
